Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Food Stamp Benefits May Lower Health Care CostsFrequent Blood Donations Safe for Some, But Not AllDrone Sets New Record for Transporting Blood SamplesGun Injuries Add Millions of Dollars to Hospital CostsACP Does Not Support Legalization of Assisted SuicideAAP: Few Doctors Provide Firearm Injury Prevention Info in ER9 of 10 Docs Unprepared to Prescribe MarijuanaThis Mistake Can Cost Athletes' Lives in Cardiac ArrestDrills Assess ER Response to Communicable DiseaseDo Nursing Home Workers Change Gloves Often Enough?Minorities Exposed to Dirtier Air, U.S. Study FindsPhysicians Tweeting About Drugs May Have Conflict of Interest'Science Spin' Found Prevalent in Biomedical LiteratureHealth Tip: Overcoming the Obesity EpidemicU.S. Military Surgeons Helped More Than 6,000 Afghan AdultsWhat You Can Do to Help Fight the Opioid EpidemicAre Physicians Obligated to Help on Planes?Median Cost of Cancer Drug Development $648.0 MillionDoes Study Claim a Cure? Beware of Scientific 'Spin'Vaccine Campaign in Poor Countries to Save 20 Million LivesThird Dose of MMR Vaccine Could Help Curb Mumps OutbreaksDocs Should Be Aware of Family Beliefs Regarding NondisclosureIncrease in Medical Exemptions From Immunization in CaliforniaMailed Invitations Increase CRC Screening CompletionMany Americans Getting Medical Care They Don't NeedInsurer Aetna's Envelopes Revealed Customers' HIV StatusHealth Groups Demand 'R' Rating for Movies That Show SmokingGoogle Search for 'Depression' Now to Provide Screening TestPatients' Hearing Loss May Mean Poorer Medical CareFDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?Steep Price Hikes Led to Drop in Use of 2 Heart Drugs at U.S. HospitalsAPA: Medical Discrimination Based on Size Stresses Patients2 of 3 U.S. Patients Keep Unused Painkillers After SurgeryMedical Reality Catches Up to Science FictionFDA Looks to Reduce Nicotine in CigarettesAHA Hands-Only CPR Training Kiosks Available at More Airports$100 Sweetens the Pot for a ColonoscopyJust a Few Vaccine Refusers Could Endanger ManyASCO Addresses Cancer Drug PricingHigh Court Rules Against Interstate Medical LiabilityFewer U.S. Dollars Spent on Cardiac Arrest Research: StudyPainkiller Prescriptions More Prone to Errors If HandwrittenFDA Panel OKs What May Soon Be First Gene Therapy Approved in U.S.Walking Rates Are Key to a Country's Obesity LevelsDocs Should Counsel Even Healthy People on Diet, Exercise, Experts SayHealth Service Use Unchanged From 1996-1997 to 2011-2012Easier Colon Exam Boosts Screening, But Insurers May Not PayMore U.S. Patients Are Recording Their Doctor Visits
Questions and AnswersLinksBook Reviews
Related Topics

No Routine Screening for Thyroid Cancer: Expert Panel

HealthDay News
by -- Mary Elizabeth Dallas
Updated: May 9th 2017

new article illustration

TUESDAY, May 9, 2017 (HealthDay News) -- Doctors shouldn't routinely screen adults for thyroid cancer if they have no symptoms or warning signs of the disease, according to the U.S. Preventative Services Task Force (USPSTF).

Doing so could cause more harm than good, said the independent panel of experts as it reaffirmed guidelines it issued in 1996 and 2016.

"While there is very little evidence of the benefits of screening for thyroid cancer, there is considerable evidence of the serious harms of treatment, such as damage to the nerves that control speaking and breathing," said panel member Karina Davidson in a USPSTF news release.

"What limited evidence is available does not suggest that screening enables people to live longer, healthier lives," she said.

The thyroid is a hormone-producing gland located in the neck. The hormones produced by the thyroid help regulate the body's metabolism. There is more than one type of thyroid cancer, but the disease is rare in the United States. Thyroid cancer represents less than 4 percent of all new cancer diagnoses in 2017, the USPSTF said.

The task force reviewed the available evidence on the benefits and risks of screening.

And while screening for the disease does increase the number of people diagnosed with thyroid cancer, it doesn't reduce death rates associated with the disease, the USPSTF concluded.

"Overdiagnosis occurs because screening for thyroid cancer often identifies small or slow growing tumors that might never affect a person during their lifetime," said USPSTF member Dr. Seth Landefeld.

"People who are treated for these small tumors are exposed to serious risks from surgery or radiation, but do not receive any real benefit," he said.

The USPSTF recommendation was published online May 9 in the Journal of the American Medical Association. It is also on the USPSTF website at www.uspreventiveservicestaskforce.org.

More information

The American Cancer Society provides more information on thyroid cancer.